Biotech Beam Therapeutics Inc (NASDAQ:BEAM) has taken a more than 50% haircut off its Feb 18, 12-month high of $35.25. The shares have traded in a tight range for the last two months, with a …
Top Stock Pick Report: V-Shaped Rallies Everywhere
view original post